Accuracy of a prediction model for heparin-induced thrombocytopenia (HIT): An analysis based on individual patient data

被引:3
|
作者
Garcia Junqueira, Daniela Rezende [1 ]
Viana, Thercia Guedes [1 ]
Carvalho, Maria das Gracas [2 ]
Perini, Edson [1 ]
机构
[1] Univ Fed Minas Gerais, Ctr Drug Studies Cemed, Dept Social Pharm, Sch Pharm, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Sch Pharm, Belo Horizonte, MG, Brazil
关键词
Heparin; Adverse drug reaction; Diagnosis; Thrombocytopenia; Diagnostic test accuracy; Algorithm; OPERATING CHARACTERISTIC CURVES; DIAGNOSIS; ANTIBODIES; MANAGEMENT; ASSAY;
D O I
10.1016/j.cca.2011.04.026
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction associated with thrombosis, and its paradoxical nature is a challenging issue for the diagnosis. The '4Ts' scoring system represents a simple and efficient way to improve clinical diagnoses of the syndrome. This system classifies patients as having high, intermediate, and low clinical probability for HIT. However, uncertainty remains concerning its clinical meaning, thus weakening the diagnostic value of this screening instrument. Methods: We analyzed the diagnostic test accuracy based on individual patient data extracted from published primary scientific studies. This study focused on 186 cases of treatment with heparin, which later evolved into a clinical suspicion of HIT. Upon choosing the most appropriate reference laboratory, the accuracy of the 4Ts was analyzed using the receiver operator characteristic curve analysis. Results: Half of the positive cases (57.1%) were classified as having a high score, while 25.5% of the negative cases were classified as a having low score for HIT. Slightly more than half of all patients (53.2%) were classified as having an intermediate score. As such, the pre-test instrument would most likely fail to distinguish between diseased and nondiseased patients in a relevant number of cases. The calculated accuracy of the summary indicates that the 4Ts can be considered a good, but not a defining, test. Conclusion: Further studies are warranted regarding clinical score systems, either alone or in combination with laboratory tests, in an attempt to improve the early diagnosis of this adverse drug reaction and to provide better care for at-risk patients. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1521 / 1526
页数:6
相关论文
共 50 条
  • [21] Accuracy of Diagnosing Heparin-Induced Thrombocytopenia
    Larsen, Emil List
    Nilius, Henning
    Studt, Jan-Dirk
    Tsakiris, Dimitrios A.
    Greinacher, Andreas
    Mendez, Adriana
    Schmidt, Adrian
    Wuillemin, Walter A.
    Gerber, Bernhard
    Vishnu, Prakash
    Graf, Lukas
    Hovinga, Johanna A. Kremer
    Goetze, Jens P.
    Bakchoul, Tamam
    Nagler, Michael
    JAMA NETWORK OPEN, 2024, 7 (03)
  • [22] The Use of Flow Cytometry in the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
    Malicev, Elvira
    TRANSFUSION MEDICINE REVIEWS, 2020, 34 (01) : 34 - 41
  • [23] Scoring systems for heparin-induced thrombocytopenia (HIT): Whither now?
    Warkentin, Theodore E.
    THROMBOSIS AND HAEMOSTASIS, 2015, 113 (03) : 437 - 438
  • [24] Heparin-Induced Thrombocytopenia at the Emergency Department Due to Intermittent Heparin Flush in a Patient Undergoing Stem Cell Transplant
    Thein, Kyaw Z.
    Elsaim, Sarah A.
    Ma, Maggie Q.
    Hernandez, Cristhiam M. Rojas
    Elsayem, Ahmed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [25] Pathophysiology, epidemiology, diagnosis and treatment of heparin-induced thrombocytopenia (HIT)
    Picker, SM
    Gathof, BS
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2004, 9 (04) : 180 - 185
  • [26] Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases
    Kadidal, VV
    Mayo, DJ
    Horne, MK
    JOURNAL OF INTERNAL MEDICINE, 1999, 246 (03) : 325 - 329
  • [27] Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes
    Prechel, Margaret
    Hudec, Susan
    Lowden, Elizabeth
    Escalante, Vicki
    Emanuele, Nicholas
    Emanuele, Maryann
    Walenga, Jeanine M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 : 294S - 300S
  • [28] Molecular and cellular pathogenesis of heparin-induced thrombocytopenia (HIT)
    Rauova, Lubica
    Arepally, Gowthami
    Poncz, Mortimer
    Cines, Douglas B.
    AUTOIMMUNITY REVIEWS, 2018, 17 (10) : 1046 - 1052
  • [29] Heparin-induced thrombocytopenia (HIT II) in liver transplant recipients: a retrospective multivariate analysis of prognostic factors
    Hueser, Norbert
    Assfalg, Volker
    Reim, Daniel
    Novotny, Alexander
    Thorban, Stefan
    Cheng, Zhangjun
    Kornberg, Arno
    Friess, Helmut
    Buechler, Peter
    Matevossian, Edouard
    TRANSPLANT INTERNATIONAL, 2012, 25 (07) : 739 - 747
  • [30] Heparin-induced thrombocytopenia (HIT): Clinical and economic outcomes
    Baroletti, Steven
    Piovella, Chiara
    Fanikos, John
    Labreche, Matthew
    Lin, Jay
    Goldhaber, Samuel Z.
    THROMBOSIS AND HAEMOSTASIS, 2008, 100 (06) : 1130 - 1135